Profil
Ruth B.
Kunath served a Director of Dendreon Corp.
from December 1999 to June 4, 2008.
She was Biotechnology Portfolio Manager of Vulcan, Inc. from 1991 to November 2003 and worked at Seattle Capital Management.
Ms. Kunath was Senior Portfolio Manager for the Healthcare Sector of Bank of America Capital Management.
She received a BA degree from DePauw University and is a Chartered Financial Analyst.
Ehemalige bekannte Positionen von Ruth B. Kunath
Unternehmen | Position | Ende |
---|---|---|
DENDREON CORPORATION | Direktor/Vorstandsmitglied | 04.06.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |